CompanyJuly 27, 2026364 Views
Huayuu Biopharma Completes Series B Funding
The company successfully completed Series B funding .
Hangzhou Huayuu Biopharma Co., Ltd. (HUAYUU) recently announced the completion of Series B funding , led by several renowned investment institutions. The funds will be used to accelerate clinical advancement of core pipelines and industrial base construction.

